OMV AG/ AT0000743059 /
5/16/2024 12:10:05 PM | Chg. - | Volume | Bid9:00:18 AM | Ask9:00:18 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
46.97EUR | - | 5 Turnover: 234.85 |
-Bid Size: - | -Ask Size: - | 15.33 bill.EUR | 10.77% | 10.35 |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/2/2021
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...